Next Article in Journal
The Engineered Drug 3′UTRMYC1-18 Degrades the c-MYC-STAT5A/B-PD-L1 Complex In Vivo to Inhibit Metastatic Triple-Negative Breast Cancer
Next Article in Special Issue
Vascular Biomarkers for Pulmonary Nodule Malignancy: Arteries vs. Veins
Previous Article in Journal
Enhanced Lung Cancer Detection Using a Combined Ratio of Antigen–Autoantibody Immune Complexes against CYFRA 21-1 and p53
Previous Article in Special Issue
Immune Microenvironment in Childhood Cancers: Characteristics and Therapeutic Challenges
 
 
Article

Article Versions Notes

Cancers 2024, 16(15), 2662; https://doi.org/10.3390/cancers16152662
Action Date Notes Link
article xml file uploaded 26 July 2024 11:29 CEST Original file -
article xml uploaded. 26 July 2024 11:29 CEST Update https://www.mdpi.com/2072-6694/16/15/2662/xml
article pdf uploaded. 26 July 2024 11:29 CEST Version of Record https://www.mdpi.com/2072-6694/16/15/2662/pdf
article supplementary file uploaded. 26 July 2024 11:29 CEST - https://www.mdpi.com/2072-6694/16/15/2662#supplementary
article html file updated 26 July 2024 11:31 CEST Original file https://www.mdpi.com/2072-6694/16/15/2662/html
Back to TopTop